1081 related articles for article (PubMed ID: 17549063)
1. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of antipsychoatics.
Ozaki N
Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of antipsychotics: useful for the clinician?
Bondy B; Spellmann I
Curr Opin Psychiatry; 2007 Mar; 20(2):126-30. PubMed ID: 17278909
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.
Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
Psychiatr Danub; 2010 Jun; 22(2):335-7. PubMed ID: 20562776
[TBL] [Abstract][Full Text] [Related]
5. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.
Reynolds GP; Yao Z; Zhang X; Sun J; Zhang Z
Eur Neuropsychopharmacol; 2005 Mar; 15(2):143-51. PubMed ID: 15695058
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacogenetics in the treatment of schizophrenia].
Saito M; Yasui-Furukori N; Kaneko S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):129-35. PubMed ID: 16045195
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics and tailored drug treatment in schizophrenia].
Andreassen OA; Steen VM
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2400-2. PubMed ID: 16998555
[TBL] [Abstract][Full Text] [Related]
9. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
Reynolds GP; Templeman LA; Zhang ZJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671
[TBL] [Abstract][Full Text] [Related]
10. Genetic strategies for the personalization of antipsychotic treatment.
Kerwin RW; Mancama DT; Arranz MJ
Expert Rev Mol Diagn; 2001 Sep; 1(3):275-80. PubMed ID: 11901832
[TBL] [Abstract][Full Text] [Related]
11. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
Murray M
J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics and schizophrenia.
Foster A; Miller DD; Buckley PF
Psychiatr Clin North Am; 2007 Sep; 30(3):417-35. PubMed ID: 17720030
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics as a tool in the therapy of schizophrenia.
Wilffert B; Zaal R; Brouwers JR
Pharm World Sci; 2005 Feb; 27(1):20-30. PubMed ID: 15861931
[TBL] [Abstract][Full Text] [Related]
14. The impact of pharmacogenetics on the development and use of antipsychotic drugs.
Reynolds GP
Drug Discov Today; 2007 Nov; 12(21-22):953-9. PubMed ID: 17993414
[TBL] [Abstract][Full Text] [Related]
15. [Receptor polymorphism and response to treatment in schizophrenia].
Szekeres G; Janka Z
Orv Hetil; 2002 Sep; 143(35):2027-33. PubMed ID: 12387196
[TBL] [Abstract][Full Text] [Related]
16. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.
Blanc O; Brousse G; Meary A; Leboyer M; Llorca PM
Fundam Clin Pharmacol; 2010 Apr; 24(2):139-60. PubMed ID: 19702693
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics of antipsychotics efficacy for schizophrenia.
Cacabelos R; Hashimoto R; Takeda M
Psychiatry Clin Neurosci; 2011 Feb; 65(1):3-19. PubMed ID: 21265934
[TBL] [Abstract][Full Text] [Related]
19. Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)).
Arranz MJ; Mancama D; Kerwin RW
Int J Mol Med; 2001 Jan; 7(1):27-30. PubMed ID: 11115604
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetics of antipsychotics in schizophrenia].
Méary A
Therapie; 2008; 63(3):243-6. PubMed ID: 18718213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]